In the healthcare landscape, old and new players rub shoulders in a world of exciting innovations including nanotechnology, AI and robotics. Many bumps in the road remain though. Regulatory burdens and reimbursement pressures add to the complexities of scaling and development. For investors, longer and more twisted routes to exit exist, hindering entrepreneurs and restricting investment at key stages. But the life science industry is resilient and there are plenty of reasons to be positive with political change and technological disruption likely to keep the market fast moving.
From early-stage founders looking to kick-start their journey to later-stage companies aiming to carry on as independent organisations, finding the right finance from the right people is vital. How can companies maximise their chances of success and how will strategic plans that understands growth, the customer-base and where an acquisition may be likely smooth the way?
- What are the investment trends of 2017?
- Rules of Attraction – what does a great investment look like?
- Perfect fit – corporate investors, crowd-funding and family office finance
- How much support do teams need to think strategically about investment?
Economic as well as clinical benefit is a key consideration for new innovations in MedTech and new products will be scrutinized by investors and customers alike and are expected to measure up. But what does this mean in practical terms for an early-stage company and how are investors reacting to this changing environment?
- Health economic analysis and competitive advantage
- How is this shift shaping investment choices?
- How is economic benefit bringing in new investors?
- How does healthcare economics fit with other new trends in life sciences?
Whilst there is a steady flow of early-stage entrepreneurship and visionary innovators, it is within the commercialisation stage that many companies face multiple challenges. How do company owners balance the demands of tech transfer, intellectual property protection and licensing? What time does this leave for incubating a company and seeking funding in a competitive environment?
- Incubators and partnerships
- Ideas into practice – tips for success
- Finding growth funding – practical tips
- How can you de-risk in this difficult stage?
Special pre-scheduled individual One-To-One meetings will be taking place in our dedicated meeting area. This session will consist of 4 x 20min One-To-One meetings.